Evaluation of Blood C Reactive Protein (CRP) and Neutrophil-to-Lymphocyte Ratio (NLR) Utility in Canine Epilepsy

Overview

Journal Vet Sci

Publisher MDPI

Specialty Veterinary Medicine

Date 2024 Sep 27

PMID 39330787

Authors

Andreea Despa

Mihai Musteata

Gheorghe Solcan

Affiliations

Soon will be listed here.

Abstract

Background: The role of neuroinflammation in epileptogenesis has been previously explored, and several biomarkers have been identified as being relevant in assessing the intensity of the inflammatory process. In human medicine, an increased C reactive protein (CRP) blood concentration and/or neutrophil-to-lymphocyte ratio (NLR) is considered a constant finding of epileptic activity. In veterinary medicine, only a few studies have been published regarding both of these topics.

Hypothesis/objectives: Our aim was to assess the C reactive protein blood concentration and the neutrophil-to-lymphocyte ratio in epileptic dogs, regardless of etiology.

Method: This retrospective study was based on changes in routine blood parameters in 59 dogs with epileptic activity.

Results: An increased C reactive protein concentration was observed mostly in the dogs affected by structural epilepsy, and all epileptic dogs displayed abnormal neutrophil-to-lymphocyte values.

Conclusions: Based on the authors' knowledge, this is the first report regarding the NLR in epileptic dogs. Both the CRP concentration and the NLR might be considered feasible non-specific markers of the neuroinflamation involved in epileptogenesis and might be used in the diagnosis of and therapeutic approach to cluster seizures in dogs with idiopathic epilepsy and in patients with structural epilepsy. Dogs diagnosed with IEis and high CRP concentrations and NLRs may be subject to non-documented cluster seizures. Both CRP and the NLR have limited diagnostic value in dogs with reactive seizures.

References

Armasu M, Packer R, Cook S, Solcan G, Volk H . An exploratory study using a statistical approach as a platform for clinical reasoning in canine epilepsy. Vet J. 2014; 202(2):292-6. DOI: 10.1016/j.tvjl.2014.08.008. View

Vega J, Komisaruk B, Stewart M . Hiding in plain sight? A review of post-convulsive leukocyte elevations. Front Neurol. 2022; 13:1021042. PMC: 9666487. DOI: 10.3389/fneur.2022.1021042. View

Nowakowska M, Ucal M, Charalambous M, Bhatti S, Denison T, Meller S . Neurostimulation as a Method of Treatment and a Preventive Measure in Canine Drug-Resistant Epilepsy: Current State and Future Prospects. Front Vet Sci. 2022; 9:889561. PMC: 9244381. DOI: 10.3389/fvets.2022.889561. View

Malin K, Witkowska-Pilaszewicz O . C-Reactive Protein as a Diagnostic Marker in Dogs: A Review. Animals (Basel). 2022; 12(20). PMC: 9598812. DOI: 10.3390/ani12202888. View

Pierson E, Wagner C, Goverman J . The contribution of neutrophils to CNS autoimmunity. Clin Immunol. 2016; 189:23-28. PMC: 5203971. DOI: 10.1016/j.clim.2016.06.017. View

Hindenberg S, Bauer N, Moritz A . Extremely high canine C-reactive protein concentrations > 100 mg/l - prevalence, etiology and prognostic significance. BMC Vet Res. 2020; 16(1):147. PMC: 7237877. DOI: 10.1186/s12917-020-02367-7. View

Duran-Galea A, Cristobal-Verdejo J, Barrera-Chacon R, Macias-Garcia B, Gonzalez-Solis M, Nicolas-Barcelo P . Clinical importance of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and systemic immune-inflammation index in dogs with leishmaniasis. Comp Immunol Microbiol Infect Dis. 2024; 107:102148. DOI: 10.1016/j.cimid.2024.102148. View

Mutz M, Boudreaux B, Kearney M, Stroda K, Gaunt S, Shiomitsu K . Prognostic value of baseline absolute lymphocyte concentration and neutrophil/lymphocyte ratio in dogs with newly diagnosed multi-centric lymphoma. Vet Comp Oncol. 2013; 13(4):337-47. DOI: 10.1111/vco.12045. View

Fischer A, Hulsmeyer V, Munoz Schmieder V, Tipold A, Kornberg M, Konig F . Cyclooxygenase-2 Inhibition as an Add-On Strategy in Drug Resistant Epilepsy-A Canine Translational Study. Front Vet Sci. 2022; 9:864293. PMC: 9021788. DOI: 10.3389/fvets.2022.864293. View

10.

De Risio L, Bhatti S, Munana K, Penderis J, Stein V, Tipold A . International veterinary epilepsy task force consensus proposal: diagnostic approach to epilepsy in dogs. BMC Vet Res. 2015; 11:148. PMC: 4552251. DOI: 10.1186/s12917-015-0462-1. View

11.

Charalambous M, Munana K, Patterson E, Platt S, Volk H . ACVIM Consensus Statement on the management of status epilepticus and cluster seizures in dogs and cats. J Vet Intern Med. 2023; 38(1):19-40. PMC: 10800221. DOI: 10.1111/jvim.16928. View

12.

Yoon J, Kim S, Kang J, Park J, Yu D . Alterations in serum protein electrophoresis profiles during the acute phase response in dogs with acute pancreatitis. Can J Vet Res. 2020; 84(1):74-78. PMC: 6923814. View

13.

Park J, Lee D, Yun T, Koo Y, Chae Y, Kim H . Evaluation of the blood neutrophil-to-lymphocyte ratio as a biomarker for meningoencephalitis of unknown etiology in dogs. J Vet Intern Med. 2022; 36(5):1719-1725. PMC: 9511057. DOI: 10.1111/jvim.16512. View

14.

Chiti L, Ferrari R, Boracchi P, Morello E, Marconato L, Roccabianca P . Prognostic impact of clinical, haematological, and histopathological variables in 102 canine cutaneous perivascular wall tumours. Vet Comp Oncol. 2021; 19(2):275-283. DOI: 10.1111/vco.12673. View

15.

Becher A, Suchodolski J, Steiner J, Heilmann R . Blood neutrophil-to-lymphocyte ratio (NLR) as a diagnostic marker in dogs with chronic enteropathy. J Vet Diagn Invest. 2021; 33(3):516-527. PMC: 8120068. DOI: 10.1177/1040638721992057. View

16.

Charalambous M, Fischer A, Potschka H, Walker M, Raedt R, Vonck K . Translational veterinary epilepsy: A win-win situation for human and veterinary neurology. Vet J. 2023; 293:105956. DOI: 10.1016/j.tvjl.2023.105956. View

17.

Wong V, Kidney B, Snead E, Myers S, Jackson M . Serum C-reactive protein concentrations in healthy Miniature Schnauzer dogs. Vet Clin Pathol. 2011; 40(3):380-3. DOI: 10.1111/j.1939-165X.2011.00336.x. View

18.

Roesler R, Dini S, Isolan G . Neuroinflammation and immunoregulation in glioblastoma and brain metastases: Recent developments in imaging approaches. Clin Exp Immunol. 2021; 206(3):314-324. PMC: 8561695. DOI: 10.1111/cei.13668. View

19.

Galezowski A, Snead E, Kidney B, Jackson M . C-reactive protein as a prognostic indicator in dogs with acute abdomen syndrome. J Vet Diagn Invest. 2010; 22(3):395-401. DOI: 10.1177/104063871002200308. View

20.

Cavalerie R, Santos A, Leonardi H, Blond L, Beurlet S, Dumont R . C-reactive protein concentration has limited value in the diagnosis of meningoencephalitis of unknown origin in dogs. J Am Vet Med Assoc. 2024; 262(4):481-488. DOI: 10.2460/javma.23.11.0606. View